About the Authors
- Craig W. Hendrix
-
* E-mail: chendrix@jhmi.edu
Affiliation Department of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America
- Beatrice A. Chen
-
Affiliation Center for Family Planning Research and Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
- Vijayanand Guddera
-
Affiliation South African Medical Research Council, Durban, South Africa
- Craig Hoesley
-
Affiliation Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America
- Jessica Justman
-
Affiliation ICAP, Mailman School of Public Health, Columbia University, New York, New York, United States of America
- Clemensia Nakabiito
-
Affiliation MU-JHU Research Collaboration, Kampala, Uganda
- Robert Salata
-
Affiliation Department of Medicine, Case Western Reserve University, Cleveland, Ohio, United States of America
- Lydia Soto-Torres
-
Affiliation Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
- Karen Patterson
-
Affiliation Department of Biostatistics, University of Washington, Seattle, Washington, United States of America
- Alexandra M. Minnis
-
Affiliations Women’s Global Health Imperative, RTI International, San Francisco, California, United States of America, School of Public Health, University of California, Berkeley, California, United States of America
- Sharavi Gandham
-
Affiliation SCHARP, Seattle, Washington, United States of America
- Kailazarid Gomez
-
Affiliation FHI 360, Research Triangle Park, North Carolina, United States of America
- Barbra A. Richardson
-
Affiliation Department of Biostatistics, University of Washington, Seattle, Washington, United States of America
- Namandje N. Bumpus
-
Affiliation Department of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America
Competing Interests
CONRAD provided regulatory support for the tenofovir gel IND given their ongoing management of tenofvoir gel development. However, NIH held the IND for the tenofovir gel in this study, not CONRAD, not Gilead. CONRAD did not provide financial support. Gilead had no role in this study - neither the design, drug supply, data collection and analysis, decision to publish, or preparation of the manuscript. MTN paid for the tenofovir gel. Finally, there are no restrictions to data from MTN-001 which is controlled by CONRAD or Gilead Sciences. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: CWH BAC VG JJ CN RS LST AMM KG BAR. Performed the experiments: CWH BAC VG CH JJ CN RS LST KP AMM SG KG BAR NNB. Analyzed the data: CWH KP AMM SG BAR NNB. Wrote the paper: CWH BAC VG CH JJ CN RS LST KP AMM SG KG BAR NNB.